PEOPLE - Scottish Hospital Endowments Research Trust re-appoints:
This article was originally published in Clinica
Executive Summary
Jane Bower, Graham Beastall and David Grahame have been re-appointed to the Scottish Hospital Endowments Research Trust (SHERT). Professor Bower is a specialist in human genetics and the commercialisation of academic science and technology; she is a member of the Scottish Stem Cell Steering Group, among other bodies. Dr Beastall is a consultant clinical scientist in clinical biochemistry for NHS Greater Glasgow, and fellow (and former vice-president) of the Royal College of Pathologists. Mr Grahame specialises in commercialising Scottish R&D intellectual property and is a member of, among other things, the European Business Angels Network.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.